259 related articles for article (PubMed ID: 3703609)
1. Age-related alterations of immunoreactive pancreatic cationic trypsinogen in sera from cystic fibrosis patients with and without pancreatic insufficiency.
Durie PR; Forstner GG; Gaskin KJ; Moore DJ; Cleghorn GJ; Wong SS; Corey ML
Pediatr Res; 1986 Mar; 20(3):209-13. PubMed ID: 3703609
[TBL] [Abstract][Full Text] [Related]
2. Plasma immunoreactive pancreatic cationic trypsinogen in cystic fibrosis: a sensitive indicator of exocrine pancreatic dysfunction.
Durie PR; Largman C; Brodrick JW; Johnson JH; Gaskin KJ; Forstner GG; Geokas MC
Pediatr Res; 1981 Oct; 15(10):1351-5. PubMed ID: 7301457
[TBL] [Abstract][Full Text] [Related]
3. Serum immunoreactive pancreatic lipase and cationic trypsinogen for the assessment of exocrine pancreatic function in older patients with cystic fibrosis.
Cleghorn G; Benjamin L; Corey M; Forstner G; Dati F; Durie P
Pediatrics; 1986 Mar; 77(3):301-6. PubMed ID: 3951910
[TBL] [Abstract][Full Text] [Related]
4. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
De Boeck K; Weren M; Proesmans M; Kerem E
Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal evaluation of serum trypsinogen measurement in pancreatic-insufficient and pancreatic-sufficient patients with cystic fibrosis.
Couper RT; Corey M; Durie PR; Forstner GG; Moore DJ
J Pediatr; 1995 Sep; 127(3):408-13. PubMed ID: 7658271
[TBL] [Abstract][Full Text] [Related]
6. Abnormalities of circulating immunoreactive pancreatic anionic trypsinogen in cystic fibrosis: an assay artifact due to cross-reacting serum antibodies.
Moore DJ; Largman C; Kopelman HR; Wong S; Durie PR
Clin Biochem; 1986 Oct; 19(5):303-7. PubMed ID: 3769196
[TBL] [Abstract][Full Text] [Related]
7. Age-related alterations in immunoreactive pancreatic lipase and cationic trypsinogen in young children with cystic fibrosis.
Cleghorn G; Benjamin L; Corey M; Forstner G; Dati F; Durie P
J Pediatr; 1985 Sep; 107(3):377-81. PubMed ID: 4032133
[TBL] [Abstract][Full Text] [Related]
8. Faecal elastase-1 and fat-soluble vitamin profiles in patients with cystic fibrosis in Western Norway.
Dorlöchter L; Aksnes L; Fluge G
Eur J Nutr; 2002 Aug; 41(4):148-52. PubMed ID: 12242582
[TBL] [Abstract][Full Text] [Related]
9. Genetic and physiologic correlates of longitudinal immunoreactive trypsinogen decline in infants with cystic fibrosis identified through newborn screening.
Sontag MK; Corey M; Hokanson JE; Marshall JA; Sommer SS; Zerbe GO; Accurso FJ
J Pediatr; 2006 Nov; 149(5):650-657. PubMed ID: 17095337
[TBL] [Abstract][Full Text] [Related]
10. Immunoreactive pancreatic Reg protein in sera from cystic fibrosis patients with and without pancreatic insufficiency.
Carrère J; Guy-Crotte O; Gaia E; Figarella C
Gut; 1999 Apr; 44(4):545-51. PubMed ID: 10075963
[TBL] [Abstract][Full Text] [Related]
11. Treatment failure in celiac disease due to coexistent exocrine pancreatic insufficiency.
Weizman Z; Hamilton JR; Kopelman HR; Cleghorn G; Durie PR
Pediatrics; 1987 Dec; 80(6):924-6. PubMed ID: 3684405
[TBL] [Abstract][Full Text] [Related]
12. Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT.
Van de Vijver E; Desager K; Mulberg AE; Staelens S; Verkade HJ; Bodewes FA; Malfroot A; Hauser B; Sinaasappel M; Van Biervliet S; Behm M; Pelckmans P; Callens D; Veereman-Wauters G
J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):61-4. PubMed ID: 21694537
[TBL] [Abstract][Full Text] [Related]
13. Exocrine pancreatic function testing in patients with cystic fibrosis and pancreatic sufficiency: a correlation study.
Weintraub A; Blau H; Mussaffi H; Picard E; Bentur L; Kerem E; Stankiewicz H; Wilschanski M
J Pediatr Gastroenterol Nutr; 2009 Mar; 48(3):306-10. PubMed ID: 19274786
[TBL] [Abstract][Full Text] [Related]
14. The changing face of the exocrine pancreas in cystic fibrosis: the correlation between pancreatic status, pancreatitis and cystic fibrosis genotype.
Augarten A; Ben Tov A; Madgar I; Barak A; Akons H; Laufer J; Efrati O; Aviram M; Bentur L; Blau H; Paret G; Wilschanski M; Kerem BS; Yahav Y
Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):164-8. PubMed ID: 18301294
[TBL] [Abstract][Full Text] [Related]
15. Use of fecal elastase-1 to classify pancreatic status in patients with cystic fibrosis.
Borowitz D; Baker SS; Duffy L; Baker RD; Fitzpatrick L; Gyamfi J; Jarembek K
J Pediatr; 2004 Sep; 145(3):322-6. PubMed ID: 15343184
[TBL] [Abstract][Full Text] [Related]
16. Serum immunoreactive cationic trypsinogen: a useful indicator of severe exocrine dysfunction in the paediatric patient without cystic fibrosis.
Moore DJ; Forstner GG; Largman C; Cleghorn GJ; Wong SS; Durie PR
Gut; 1986 Nov; 27(11):1362-8. PubMed ID: 3792918
[TBL] [Abstract][Full Text] [Related]
17. Serum pancreatic enzymes define the pancreatic phenotype in patients with Shwachman-Diamond syndrome.
Ip WF; Dupuis A; Ellis L; Beharry S; Morrison J; Stormon MO; Corey M; Rommens JM; Durie PR
J Pediatr; 2002 Aug; 141(2):259-65. PubMed ID: 12183724
[TBL] [Abstract][Full Text] [Related]
18. [Effect of nutritional status on absorption kinetics of vitamin E in mucoviscidosis].
Skopnik H; Karl M; Kusenbach G; Bergt U; Geron M; Heimann G
Klin Padiatr; 1990; 202(1):43-9. PubMed ID: 2314001
[TBL] [Abstract][Full Text] [Related]
19. Decline of exocrine pancreatic function in cystic fibrosis patients with pancreatic sufficiency.
Couper RT; Corey M; Moore DJ; Fisher LJ; Forstner GG; Durie PR
Pediatr Res; 1992 Aug; 32(2):179-82. PubMed ID: 1508606
[TBL] [Abstract][Full Text] [Related]
20. [Relation between gene mutations and pancreatic exocrine function in patients with cystic fibrosis].
Radivojević D; Guć-Sćekić M; Djurisić M; Lalić T; Minić P; Kanavakis E
Srp Arh Celok Lek; 2001; 129 Suppl 1():6-9. PubMed ID: 15637983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
